Clinical Trials Logo

Salivary Gland Acinic Cell Tumor clinical trials

View clinical trials related to Salivary Gland Acinic Cell Tumor.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00095563 Completed - Clinical trials for Recurrent Salivary Gland Cancer

Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

Start date: September 2004
Phase: Phase 2
Study type: Interventional

Phase II trial to study the effectiveness of lapatinib in treating patients who have recurrent and/or metastatic adenoid cystic cancer or other salivary gland cancers. Lapatinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth.